mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.051 |
0.8 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
Nilotinib |
FIMM |
pan-cancer |
AAC |
0.05 |
0.8 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.8 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.8 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |